Volume 145, Issue 1, Pages e8 (July 2013)

Slides:

Advertisements

Similar presentations

Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.

Advertisements

Volume 146, Issue 1, Pages e1 (January 2014)

Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease

Volume 141, Issue 5, Pages e5 (November 2011)

Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case–Control and Cohort Studies Guillaume Pineton de Chambrun, Luc.

Huiqin He, Zhinong Jiang, Leimin Sun Gastroenterology

Reply Gastroenterology

Incidence of Autoimmune Diseases in Celiac Disease: Protective Effect of the Gluten- Free Diet Jacques Cosnes, Christophe Cellier, Sheila Viola, Jean–Frederic.

Volume 143, Issue 2, Pages e1 (August 2012)

Covering the Cover Gastroenterology

Nadir Arber, Bernard Levin Gastroenterology

Volume 147, Issue 4, Pages e7 (October 2014)

Gauree Gupta, Ebbing Lautenbach, James D. Lewis

Covering the Cover Gastroenterology

Long-term Follow-up Reveals Low Incidence of Colorectal Cancer, but Frequent Need for Resection, Among Australian Patients With Inflammatory Bowel Disease

Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010 Tine Jess, Morten Frisch, Jacob Simonsen

Volume 142, Issue 2, Pages (February 2012)

Volume 137, Issue 2, Pages (August 2009)

Volume 138, Issue 5, Pages e2 (May 2010)

Unusual Case of an Upset Stomach

Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies Tine Jess, Christine Rungoe, Laurent.

Eva Wertheimer, Marcelo G. Kazanietz Gastroenterology

Covering the Cover Gastroenterology

Volume 155, Issue 4, Pages (October 2018)

Volume 149, Issue 6, Pages e1 (November 2015)

Amnon Sonnenberg, MD, MSc, Brent Y. Lee, MD

Volume 153, Issue 3, Pages e16-e17 (September 2017)

A Historical Perspective on Clinical Advances in Pancreatic Diseases

Multiple Masses in the Colon of a Patient With Ulcerative Colitis

Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia Gene K. Ma, Uri Ladabaum Clinical Gastroenterology.

Clinical Features, Treatment, and Survival of Patients With Colorectal Cancer With or Without Inflammatory Bowel Disease Raja Affendi Raja Ali, Cara.

Reply Gastroenterology

Volume 152, Issue 1, Pages (January 2017)

Volume 155, Issue 2, Pages e10 (August 2018)

Risk of Nonmelanoma Skin Cancer in Patients With Inflammatory Bowel Disease Who Use Thiopurines Is Not Increased Fiona D.M. van Schaik, Martijn G.H.

Issue Highlights Clinical Gastroenterology and Hepatology

When Should Screening Stop for Elderly Individuals at Average and Increased Risk for Colorectal Cancer? Folasade P. May, Samir Gupta Clinical Gastroenterology.

Volume 155, Issue 3, Pages (September 2018)

Volume 142, Issue 7, Pages e2 (June 2012)

Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis

Volume 143, Issue 2, Pages e1 (August 2012)

Coffee and Colorectal Cancer: Grounds for Prevention?

Genetic Testing for Hereditary Colorectal Cancer: Challenges in Identifying, Counseling, and Managing High-Risk Patients Elena M. Stoffel, Anu Chittenden

Volume 136, Issue 5, Pages (May 2009)

Volume 130, Issue 4, Pages (April 2006)

Antoine Debourdeau, Anne Bozon, Romain Altwegg Gastroenterology

Caitlin C. Murphy, Kristin Wallace, Robert S. Sandler, John A. Baron

Volume 150, Issue 2, Pages e4 (February 2016)

Heiko Pohl, Douglas J. Robertson

Volume 156, Issue 5, Pages e3 (April 2019)

Volume 140, Issue 6, Pages e2 (May 2011)

Gender as a Risk Factor for Advanced Neoplasia and Colorectal Cancer: A Systematic Review and Meta-analysis Stephen P. Nguyen, Stephen Bent, Yea-Hung.

Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Nationwide Population- based Cohort Study With 30 Years of Follow-up Evaluation Michael.

The Dawning of a New Editorial Board for Gastroenterology

Volume 151, Issue 4, Pages (October 2016)

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

Meenakshi Bewtra, Chinyu Su, James D. Lewis

Michiel Bronswijk, Gert De Hertogh, Marc Ferrante Gastroenterology

Volume 156, Issue 4, Pages (March 2019)

Daniel Mønsted Shabanzadeh, Lars Tue Sørensen, Torben Jørgensen

A Surprising Case of Acute Diarrhea in the South of France

Volume 145, Issue 5, Pages e3 (November 2013)

Volume 139, Issue 6, Pages e1 (December 2010)

Volume 138, Issue 6, Pages (May 2010)

Epidemiology and Natural History of Inflammatory Bowel Diseases

Volume 146, Issue 1, Pages e1 (January 2014)

Electronic Clinical Challenges and Images in GI

Tawfik Khoury, Eran Israeli, Shaul Yaari Gastroenterology

Use of Phosphodiesterase 5 Inhibitors Is Associated With Lower Risk of Colorectal Cancer in Men With Benign Colorectal Neoplasms Wuqing Huang, Jan Sundquist,

Thiopurines and Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease: A Meta-analysis Tine Jess, Anthony Lopez, Mikael Andersson,

Presentation transcript:

Volume 145, Issue 1, Pages 166-175.e8 (July 2013) Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease Laurent Beaugerie, Magali Svrcek, Philippe Seksik, Anne–Marie Bouvier, Tabassome Simon, Matthieu Allez, Hedia Brixi, Jean–Marc Gornet, Romain Altwegg, Philippe Beau, Bernard Duclos, Arnaud Bourreille, Jean Faivre, Laurent Peyrin–Biroulet, Jean–François Fléjou, Fabrice Carrat Gastroenterology Volume 145, Issue 1, Pages 166-175.e8 (July 2013) DOI: 10.1053/j.gastro.2013.03.044 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Incidence rates of colorectal HGD and cancer according to age at entry into the cohort in all IBD patients (A), IBD patients with long-standing extensive colitis (B), and IBD patients without long-standing extensive colitis (C). Gastroenterology 2013 145, 166-175.e8DOI: (10.1053/j.gastro.2013.03.044) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Probability of remaining free of colorectal advanced neoplasia (HGD or cancer) in patients with (A) or without (B) long-standing extensive colitis according to thiopurine exposure status at the time of entry into the cohort, and probability of remaining free of CRC in patients with (C) or without (D) long-standing extensive colitis according to thiopurine exposure status at the time of entry into the cohort. Gastroenterology 2013 145, 166-175.e8DOI: (10.1053/j.gastro.2013.03.044) Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Incidence rates of colorectal advanced neoplasia grouped by IBD subtype at entry in the cohort. IBDU, inflammatory bowel disease, unclassified. Gastroenterology 2013 145, 166-175.e8DOI: (10.1053/j.gastro.2013.03.044) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Incidence rates of colorectal advanced neoplasia according to exposure to thiopurines at diagnosis of neoplasia and long-standing extensive colitis (LEC) status. Gastroenterology 2013 145, 166-175.e8DOI: (10.1053/j.gastro.2013.03.044) Copyright © 2013 AGA Institute Terms and Conditions